Abstract No. 250 Periprocedural hemodynamic instability in patients who have received both transarterial bland embolization and yttrium-90 radioembolization for neuroendocrine tumor liver metastases

Abstract

Transarterial embolization (TAE) and transarterial radioembolization with Yttrium-90 (TARE) are two common treatments for neuroendocrine tumor liver metastases (NETLMs). Hormonal release causing hemodynamic instability and carcinoid symptoms is frequently observed during bland embolization of NETLMs. The difference in likelihood of periprocedural hemodynamic instability (PPHDI) between TAE and TARE has not been explored. The purpose of our study was to compare the occurrence of PPHDI in TAE with TARE in a cohort of patients who received each treatment at different points in time.